Reference 6 - Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms
NonrulemakingSupporting & Related MaterialFDA-2026-P-6541-0008
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 9, 2026
- Agency
- Food and Drug Administration (FDA)